PATIENTS AND METHODS: Patients with ESCLC were considered eligible for the study if they were younger than 68 years, had a performance status of 0 to 2, and were free of brain metastases. Patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results